Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Pharmaceuticals & Biotech
Create a narrative
Photocure Community
OB:PHO Community
1
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Create a narrative
Photocure
Popular
Undervalued
Overvalued
Community Investing Ideas
Photocure
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Adoption Of ForTec’s Mobile Strategy Will Increase Market Penetration In The US
Key Takeaways Expanding blue light cystoscopy in Europe and the U.S. through strategic initiatives is expected to enhance market access and drive revenue growth. Success in partnerships and technology launches is likely to fuel growth, while regulatory reclassification and approvals could unlock new revenue streams.
View narrative
NOK 82.50
FV
39.4% undervalued
intrinsic discount
13.69%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
8 days ago
author updated this narrative
Your Valuation for
PHO
PHO
Photocure
Your Fair Value
NOK
Current Price
NOK 50.00
23.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-72m
992m
2015
2018
2021
2024
2025
2027
2030
Revenue NOK 991.7m
Earnings NOK 147.5m
Advanced
Set Fair Value